Tag: Featured


  • Why Market Segmentation is Critical for Manual Blood Bank Reagents

    In vitro diagnostics companies often approach blood bank reagent sales with a broad laboratory strategy: identify hospitals, present the product portfolio, negotiate contracts, and compete on service and price.

  • Inside the Clinical Laboratory: Top 5 Deficiencies Labs Think They Have Fixed… and How to Actually Fix Them

    Inspection findings rarely come from the unexpected. More often, they come from processes that appear complete, but don’t hold up under closer evaluation. Across laboratories of varying size and complexity, the same pattern emerges: deficiencies are addressed at the surface level, but the underlying system remains vulnerable. The result is recurrence, either during the next…

  • What Clinical Laboratories Wish Commercial Organizations Knew

    Medical Laboratory Professionals Week is a time to recognize the essential role laboratories play in patient care. This year’s theme: “Lab Story: To Infinity and Beyond for our Patients!” captures both the mission and the momentum of the profession.

  • Prehospital Transfusion: Expanding Access, Managing Complexity

    The evolution of transfusion medicine is increasingly defined by one central shift: moving care closer to the point of injury. Prehospital transfusion, once limited to military and select air medical programs, is now gaining traction across civilian trauma systems. The goal is straightforward: initiate resuscitation earlier, reduce time to blood product administration, and improve outcomes…

  • The Clinical Case for Whole Blood

    The renewed interest in LTOWB is rooted in trauma care. Hemostatic resuscitation strategies emphasize early, balanced replacement of red cells, plasma, and platelets. Whole blood inherently delivers this balance in a single unit.

  • Inside the Clinical Laboratory: The Evolving Role of Group O Blood in Emergency Transfusion

    For decades, Group O blood has been considered the universal solution for emergency transfusion. In situations where a patient’s blood type is unknown, O-negative red blood cells have been the default choice, minimizing the risk of acute hemolytic transfusion reactions and allowing rapid response in critical situations.

  • Leadership Patterns That Create Hidden Risk in Clinical Laboratories

    Leadership in clinical laboratories is often discussed in terms of technical expertise, regulatory knowledge, and operational oversight. All of those are essential. But some of the most significant risks in laboratory environments don’t originate from a lack of technical capability. They emerge from leadership patterns—subtle, often unintentional behaviors that influence how teams operate, communicate, and…

  • Inside the Clinical Laboratory: The Quality System Behind Every Test

    When clinicians review a laboratory result, they rarely see the infrastructure that supports it. A hemoglobin value, antibody screen, or molecular test result appears as a simple data point in the electronic medical record. But behind that single result is a complex operational framework designed to ensure the test was performed correctly, consistently, and in…

  • From Assay to Adoption: The Laboratory Reality Behind Diagnostics Commercialization

    The diagnostics industry has never been more innovative. New assays emerge every year promising earlier detection, improved clinical sensitivity, and more precise treatment decisions. Advances in molecular diagnostics, immunoassay design, and multi-omic platforms are reshaping how disease is detected and managed.

  • If I Were Inspecting Your Transfusion Service Tomorrow…

    If I were asked to evaluate your blood bank tomorrow, whether as a consultant, technical supervisor, or during a regulatory inspection, here is where I would start.